Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia
Sarah S. Evans, PharmD, and Amber B. Clemmons, PharmD, BCOP
Georgia Regents Medical Center, Augusta, Georgia, and University of Georgia College of Pharmacy, Augusta, Georgia
Authors' disclosures of potential conflicts of interest are found at the end of this article.
Sarah S. Evans, PharmD, University of Georgia College of Pharmacy, HM-1200, Augusta, GA 30912.
J Adv Pract Oncol 2015;6:370–374 |
DOI: 10.6004/jadpro.2015.6.4.7 |
© 2015 Harborside Press®
For access to the full length article, please sign in